{"id":1141,"date":"2016-08-31T09:00:01","date_gmt":"2016-08-31T09:00:01","guid":{"rendered":"https:\/\/blogs.bmj.com\/spcare\/?p=1141"},"modified":"2016-06-27T09:47:04","modified_gmt":"2016-06-27T09:47:04","slug":"shortcuts-80","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/spcare\/2016\/08\/31\/shortcuts-80\/","title":{"rendered":"Shortcuts"},"content":{"rendered":"<p><strong>JAMA Neurol. 2016 May 16. doi: 10.1001\/jamaneurol.2016.0383. [Epub ahead of print]<\/strong><\/p>\n<p><a href=\"http:\/\/archneur.jamanetwork.com\/article.aspx?articleid=2521475\" target=\"_blank\"><strong>The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.<\/strong><\/a><\/p>\n<p><strong>Kolb NA, Smith AG, Singleton JR, et al<\/strong><\/p>\n<p>A secondary analysis of a prospective study was performed to determine the association between the symptoms of taxane\/platinum chemotherapy-induced peripheral neuropathy (CIPN) and the risk of falls. From 116 patients with breast, ovarian, or lung cancer, 32 had CIPN symptoms. Seventy-four falls or near falls were reported over an average follow-up of 2 months. Those with CIPN were nearly 3 times more likely to report a fall or near fall than those without, with 8\/32 (25%) with CIPN obtaining medical care for falls, compared to 6\/84 (7%) without CIPN. The authors suggest education and monitoring of patients receiving neurotoxic chemotherapy may facilitate fall prevention strategies.<\/p>\n<p>Shortcuts are compiled by Jason Boland<!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>JAMA Neurol. 2016 May 16. doi: 10.1001\/jamaneurol.2016.0383. [Epub ahead of print] The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling. Kolb NA, Smith AG, Singleton JR, et al A secondary analysis of a prospective study was performed to determine the association between the symptoms of taxane\/platinum chemotherapy-induced peripheral neuropathy (CIPN) and the [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/spcare\/2016\/08\/31\/shortcuts-80\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":275,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1982],"tags":[],"class_list":["post-1141","post","type-post","status-publish","format-standard","hentry","category-short-cuts"],"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/posts\/1141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/users\/275"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/comments?post=1141"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/posts\/1141\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/media?parent=1141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/categories?post=1141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/tags?post=1141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}